Insider Transactions in Q1 2024 at Lantheus Holdings, Inc. (LNTH)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2024
|
Robert J. Marshall Jr. CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
20,000
-14.95%
|
$1,200,000
$60.0 P/Share
|
|
Mar 13
2024
|
Andrea Sabens Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
341
-0.54%
|
$20,460
$60.48 P/Share
|
|
Mar 07
2024
|
Paul Blanchfield President |
SELL
Bona fide gift
|
Direct |
500
-0.48%
|
-
|
|
Mar 07
2024
|
Paul Blanchfield President |
SELL
Open market or private sale
|
Direct |
18,023
-14.85%
|
$1,099,403
$61.96 P/Share
|
|
Mar 06
2024
|
Sam R Leno |
SELL
Open market or private sale
|
Direct |
2,045
-1.15%
|
$128,835
$63.21 P/Share
|
|
Mar 06
2024
|
Sam R Leno |
BUY
Exercise of conversion of derivative security
|
Direct |
2,045
+3.3%
|
$32,720
$16.3 P/Share
|
|
Mar 05
2024
|
Daniel Niedzwiecki |
SELL
Payment of exercise price or tax liability
|
Direct |
8,457
-8.19%
|
$549,705
$65.36 P/Share
|
|
Mar 05
2024
|
Paul Blanchfield President |
SELL
Payment of exercise price or tax liability
|
Direct |
20,728
-14.59%
|
$1,347,320
$65.36 P/Share
|
|
Mar 05
2024
|
Andrea Sabens Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,360
-9.1%
|
$413,400
$65.36 P/Share
|
|
Mar 05
2024
|
Etienne Montagut Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,574
-21.27%
|
$1,662,310
$65.36 P/Share
|
|
Mar 05
2024
|
Robert J. Marshall Jr. CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
35,730
-21.08%
|
$2,322,450
$65.36 P/Share
|
|
Mar 05
2024
|
Sam R Leno |
SELL
Open market or private sale
|
Direct |
2,045
-1.71%
|
$130,880
$64.96 P/Share
|
|
Mar 05
2024
|
Sam R Leno |
BUY
Exercise of conversion of derivative security
|
Direct |
2,045
+3.3%
|
$32,720
$16.3 P/Share
|
|
Mar 05
2024
|
Jean Claude Provost Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Indirect |
546
-1.39%
|
$35,490
$65.36 P/Share
|
|
Mar 04
2024
|
Sam R Leno |
SELL
Open market or private sale
|
Direct |
22,389
-14.66%
|
$1,455,285
$65.2 P/Share
|
|
Mar 04
2024
|
Sam R Leno |
BUY
Exercise of conversion of derivative security
|
Direct |
22,389
+7.11%
|
$537,336
$24.77 P/Share
|
|
Mar 04
2024
|
Robert J. Marshall Jr. CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
29,762
+14.94%
|
-
|
|
Mar 04
2024
|
Paul Blanchfield President |
BUY
Grant, award, or other acquisition
|
Direct |
16,910
+10.63%
|
-
|
|
Mar 04
2024
|
Mary Anne Heino Director |
SELL
Open market or private sale
|
Direct |
93,863
-9.69%
|
$6,101,095
$65.54 P/Share
|
|
Mar 04
2024
|
Mary Anne Heino Director |
BUY
Grant, award, or other acquisition
|
Direct |
81,169
+19.02%
|
-
|
|
Mar 04
2024
|
Etienne Montagut Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,645
+15.26%
|
-
|
|
Mar 04
2024
|
Daniel Niedzwiecki |
BUY
Grant, award, or other acquisition
|
Direct |
6,466
+5.9%
|
-
|
|
Mar 04
2024
|
Andrea Sabens Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,817
+7.68%
|
-
|
|
Mar 01
2024
|
Robert J. Marshall Jr. CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
36,547
+20.73%
|
-
|
|
Mar 01
2024
|
Paul Blanchfield President |
BUY
Grant, award, or other acquisition
|
Direct |
36,547
+22.6%
|
-
|
|
Mar 01
2024
|
Jean Claude Provost Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
18,564
+32.03%
|
-
|
|
Mar 01
2024
|
Etienne Montagut Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,326
+24.11%
|
-
|
|
Mar 01
2024
|
Daniel Niedzwiecki |
BUY
Grant, award, or other acquisition
|
Direct |
30,456
+23.94%
|
-
|
|
Mar 01
2024
|
Brian A Markison CEO |
BUY
Grant, award, or other acquisition
|
Direct |
131,496
+46.25%
|
-
|
|
Mar 01
2024
|
Andrea Sabens Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,685
+8.15%
|
-
|
|
Feb 13
2024
|
Andrea Sabens Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
341
-0.58%
|
$18,755
$55.31 P/Share
|
|
Jan 16
2024
|
Andrea Sabens Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
341
-0.58%
|
$19,096
$56.01 P/Share
|